Organisation: Amryt Pharma

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Amryt gets American regulatory boost
Amryt gets American regulatory boost
Shares in Irish-listed speciality drug firm Amryt Pharma rose by 4% yesterday on the back of the company gaining orphan drug designation in the US for one of its compounds.

Tue, 08 Nov, 2016

Amryt Pharma gets US patent for headline drug
Amryt Pharma gets US patent for headline drug
Amryt Pharma has been granted a US patent for its lead drug to be used as a treatment in the lucrative orphan disease market.

Wed, 14 Sep, 2016

Amryt Pharma targets €1.3bn orphan disease market
Amryt Pharma targets €1.3bn orphan disease market

Dublin-listed drug firm Amryt Pharma is planning to widen the scope of its late-stage wound-healing drug this year, to target the $1.5bn (€1.3bn) orphan disease market.

Fri, 10 Jun, 2016

Fastnet Equity in €37m debut deal
Fastnet Equity in €37m debut deal

Dublin-based investment firm Fastnet Equity has reached conditional agreement to acquire drug firm Amryt Pharmaceuticals for £29.6m (€37.5m).

Fri, 01 Apr, 2016

Latest

Mick Clifford
Mick Clifford

News

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited